Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Period	Milestone	Group	Participants
Initial 24 Weeks	STARTED	Placebo	46
Initial 24 Weeks	STARTED	BA058 20 µg	43
Initial 24 Weeks	STARTED	BA058 40 µg	43
Initial 24 Weeks	STARTED	BA058 80 µg	45
Initial 24 Weeks	STARTED	Teriparatide	45
Initial 24 Weeks	COMPLETED	Placebo	42
Initial 24 Weeks	COMPLETED	BA058 20 µg	33
Initial 24 Weeks	COMPLETED	BA058 40 µg	36
Initial 24 Weeks	COMPLETED	BA058 80 µg	34
Initial 24 Weeks	COMPLETED	Teriparatide	39
Initial 24 Weeks	NOT COMPLETED	Placebo	4
Initial 24 Weeks	NOT COMPLETED	BA058 20 µg	10
Initial 24 Weeks	NOT COMPLETED	BA058 40 µg	7
Initial 24 Weeks	NOT COMPLETED	BA058 80 µg	11
Initial 24 Weeks	NOT COMPLETED	Teriparatide	6
Extended 24 Weeks of Treatment	STARTED	Placebo	11
Extended 24 Weeks of Treatment	STARTED	BA058 20 µg	13
Extended 24 Weeks of Treatment	STARTED	BA058 40 µg	10
Extended 24 Weeks of Treatment	STARTED	BA058 80 µg	7
Extended 24 Weeks of Treatment	STARTED	Teriparatide	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00542425/flow